ReviewHealth & social care in the community2021
Examining barriers to harm reduction and child welfare services for pregnant women and mothers who use substances using a stigma action framework.
Review in Health & social care in the community, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
46 citing papers in PubMed, 1 synthesis or guideline pooled it, 116 citations in OpenAlex.
- Why do women consume alcohol during pregnancy or while breastfeeding?Drug and alcohol review · 2022Pooled it
- Text Messaging Intervention for Postpartum Alcohol Use: Micro-Randomized Trial Supports Feasibility, Acceptability, and Maternal Message Preference.Journal of studies on alcohol and drugs · 2026Trial
- Reproductive health considerations for HIV prevention integrated care models for women who inject drugs: Qualitative perspective of participants and providers in HIV Prevention Trials Network 094.Drug and alcohol dependence · 2026Article
- The characteristics and experiences of parents accessing prescribed safer supply in BC, 2020-2021.Harm reduction journal · 2026Article
- Dying younger, dying of overdose: gendered and age dimensions of mortality and shelter service access among individuals experiencing homelessness in Toronto, Canada.BMC public health · 2026Article
- Gender and power dynamics in three types of injection partnerships among young women in rural Appalachia.Harm reduction journal · 2026Article
- Let the girls know, "you can come here": qualitative experiences with harm reduction and health services among women who use drugs in Chicago.Harm reduction journal · 2026Article
- Impact of policies on pregnant individuals using drugs: A narrative synthesis review of treatment, health care access, and outcomes.Stigma and health · 2026Article
- Strengthening the standard of care for perinatal substance use disorders: reproductive health provider perspectives on training, integration, and system improvements.Substance abuse treatment, prevention, and policy · 2026Article
- Medical-Legal Partnership: An Approach to Addressing Social and Structural Determinants of Health Among People Who Use Substances.Journal of studies on alcohol and drugs · 2026Article
- Neonatal Toxicology Testing: Ethical Considerations for Pediatricians.Hospital pediatrics · 2026Article
- Social justice with harm reduction approaches for mothers who use opioids: an international comparative ethnographic study with community engaged methods.Harm reduction journal · 2025Article
- Examining the impact of naming equity within perinatal substance use and mental health policy: a scoping review.Health research policy and systems · 2025Article
- "There are only so many fires you can put out": nonprofit structural constraints on service delivery for pregnant and postpartum women who use drugs in Appalachian North Georgia.Harm reduction journal · 2025Article
- Overdose Data to Action: A qualitative analysis of funded activities tailored for women.Journal of substance use and addiction treatment · 2025Article
- Mothering from the margins: lived experiences of incarcerated substance-abusing mothers and the developmental risks faced by their children in Sri Lanka.BMJ paediatrics open · 2025Article
- Vaping guidance and women's decision-making during pregnancy & postpartum.Public health in practice (Oxford, England) · 2025Article
- Substance Use and Drug Treatment Among Reproductive-Age Women With and Without HIV in the Southern United States.Open forum infectious diseases · 2025Article
- Gender differences in alcohol use disorder trends from 2009-2019: An intersectional analysis.Alcohol (Fayetteville, N.Y.) · 2025Article
- "I'm not a bad mother:" the experience of stigma among mothers with substance use disorder in the criminal justice system.Women & health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pregnant women and mothers who use substances often face significant barriers to accessing and engaging with substance use services. A scoping review was conducted in 2019 to understand how stigma impacts access to, retention in and outcomes of harm reduction and child welfare services for pregnant women and mothers who use substances. The forty-two (n = 42) articles were analysed using the Action Framework for Building an Inclusive Health System developed by Canada's Chief Public Health Officer to articulate the ways in which stigma and related health system barriers are experienced at the individual, interpersonal, institutional and population levels. Many articles highlighted barriers across multiple levels, 19 of which cited barriers at the individual level (i.e., fear and mistrust of child welfare services), 18 at the interpersonal level (i.e., familial and relational influence on accessing substance use treatment), 30 at the institutional level (i.e., high organisational expectations on women) and 17 at the population level (i.e., negative stereotypes and racism). Our findings highlight the interconnectedness of stigma and related barriers and the ways in which stigma at the institutional and population levels pervasively influence individual and interpersonal experiences of stigma. Despite a wealth of literature on barriers to treatment and support for pregnant women and mothers who use substances, there has been minimal focus on how systems can address these formidable barriers. This review highlights the ways in which the barriers are connected and identifies opportunities for service providers and policymakers to better support pregnant women and mothers who use substances.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.